Citation: | JU Mengxian, WANG Junjun, GUO Wancheng, WANG Yajing, FANG Penghua, ZHANG Zhenwen. Effects of celastrol on renal oxidative stress in high-fat-induced obese mice[J]. Journal of Clinical Medicine in Practice, 2023, 27(6): 106-111. DOI: 10.7619/jcmp.20223248 |
To investigate the effects and possible mechanisms of action of celastrol in regulating renal oxidative stress in high-fat diet-induced obese mice.
Twenty-four male C57BL/6 mice were equally divided into normal control group, model control group and celastrol group, with 8 mice in each group. The mice in the normal control group were fed with normal diet, while those in the model control group and celastrol group were fed with high-fat diet for 12 weeks to establish a high-fat induced obesity mouse model. Subsequently, the mice in the celastrol group were injected intraperitoneally with celastrol 100 μg/(kg·d) for 21 d. The mice in the remaining two groups were injected intraperitoneally with an equal volume of saline. Body weight, fasting blood glucose, glucose tolerance and insulin tolerance were observed in these groups. The mRNA expression levels of renal Kelch-like epichlorohydrin-associated protein 1(Keap1), nuclear factor E2-related factor 2(Nrf2) and peroxisome proliferator-activated receptor γcoactivator 1α(PGC-1α) were detected by real-time fluorescent quantitative polymerase chain reaction (RT-qPCR). The protein levels of renal Keap1, Nrf2 and PGC-1α were detected by western blot method.
The body weight and fasting blood glucose level of model control group were higher than that of normal control group, while were lower in the celastrol group than those of the model control group (P < 0.05). During drug intervention, the food intake of mice in the model control group was higher than that in the normal control group, while was lower in the celastrol group than that in model control group (P < 0.05). The results of glucose tolerance and insulin tolerance test showed that the blood glucose level of the model control group was higher than those of normal control group at each time point, while the blood glucose level of the celastrol group was lower than that of model control group (P < 0.05). Renal PGC-1α and Nrf2 gene expression and their protein levels were significantly lower than those of the normal control group, while Keap1 mRNA and Keap1 protein level were higher than those in the model control group(P < 0.05). The Nrf2 and PGC-1α mRNA in the kidney and expression levels of Nrf2 and PGC-1α protein of the celastrol group were higher than those of model control group, while expression levels of Keap1 mRNA and Keap1 protein of the celastrol group were lower than those of model control group (P < 0.05).
Celastrol can improve glucose metabolism, reduce body weight and food intake in high-fat diet-induced obese mice, play anti-inflammatory and anti-oxidative stress roles, and ameliorate renal injury. Its mechanism may be related to the renal Keap1/Nrf2/PGC-1α pathway.
[1] |
ZHENG Y, LEY S H, HU F B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications[J]. Nat Rev Endocrinol, 2018, 14(2): 88-98. doi: 10.1038/nrendo.2017.151
|
[2] |
SUN H, SAEEDI P, KARURANGA S, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J]. Diabetes Res Clin Pract, 2022, 183: 109119. doi: 10.1016/j.diabres.2021.109119
|
[3] |
THIPSAWAT S. Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: a review of the literature[J]. Diab Vasc Dis Res, 2021, 18(6): 14791641211058856.
|
[4] |
韩浩川, 张曦. 糖尿病肾病的发病机制研究[J]. 医学信息, 2021, 34(7): 39-43. doi: 10.3969/j.issn.1006-1959.2021.07.011
|
[5] |
陈海兰, 许少华, 徐伟, 等. 雷公藤红素药理活性与结构修饰研究进展[J]. 药学研究, 2020, 39(12): 722-732. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYG202012010.htm
|
[6] |
XU S H, FENG Y Q, HE W S, et al. Celastrol in metabolic diseases: progress and application prospects[J]. Pharmacol Res, 2021, 167: 105572. doi: 10.1016/j.phrs.2021.105572
|
[7] |
LIU J L, LEE J, SALAZAR HERNANDEZ M A, et al. Treatment of obesity with celastrol[J]. Cell, 2015, 161(5): 999-1011. doi: 10.1016/j.cell.2015.05.011
|
[8] |
周永强, 周维, 岳兰昕, 等. 雷公藤红素参与脂质代谢调控的研究进展[J]. 医药导报, 2021, 40(5): 587-592. https://www.cnki.com.cn/Article/CJFDTOTAL-YYDB202112020.htm
|
[9] |
郝军荣, 牛红双, 刘宜周, 等. 氧化应激在糖尿病肾病中的作用及抗氧化治疗研究进展[J]. 神经药理学报, 2020, 10(2): 33-38. doi: 10.3969/j.issn.2095-1396.2020.02.007
|
[10] |
KIAEI M, KIPIANI K, PETRI S, et al. Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis[J]. Neurodegener Dis, 2005, 2(5): 246-254. doi: 10.1159/000090364
|
[11] |
FANG P H, HE B, YU M, et al. Treatment with celastrol protects against obesity through suppression of galanin-induced fat intake and activation of PGC-1α/GLUT4 axis-mediated glucose consumption[J]. Biochim Biophys Acta Mol Basis Dis, 2019, 1865(6): 1341-1350. doi: 10.1016/j.bbadis.2019.02.002
|
[12] |
GARIANI K, MARQUES-VIDAL P, WAEBER G, et al. Salivary cortisol is not associated with incident insulin resistance or type 2 diabetes mellitus[J]. Endocr Connect, 2019, 8(7): 870-877. doi: 10.1530/EC-19-0251
|
[13] |
ABU BAKAR M H, SHARIFF K A, TAN J S, et al. Celastrol attenuates inflammatory responses in adipose tissues and improves skeletal muscle mitochondrial functions in high fat diet-induced obese rats via upregulation of AMPK/SIRT1 signaling pathways[J]. Eur J Pharmacol, 2020, 883: 173371. doi: 10.1016/j.ejphar.2020.173371
|
[14] |
HU W Y, WANG L L, DU G Z, et al. Effects of microbiota on the treatment of obesity with the natural product celastrol in rats[J]. Diabetes Metab J, 2020, 44(5): 747-763. doi: 10.4093/dmj.2019.0124
|
[15] |
SHI Y J, ZHANG W X, CHENG Y L, et al. Bromide alleviates fatty acid-induced lipid accumulation in mouse primary hepatocytes through the activation of PPARα signals[J]. J Cell Mol Med, 2019, 23(6): 4464-4474. doi: 10.1111/jcmm.14347
|
[16] |
付俊敏, 周禹, 张天泰. 雷公藤红素治疗肥胖的研究进展[J]. 中国药学杂志, 2020, 55(4): 293-297. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYX202004005.htm
|
[17] |
LUO D, GUO Y M, CHENG Y Y, et al. Natural product celastrol suppressed macrophage M1 polarization against inflammation in diet-induced obese mice via regulating Nrf2/HO-1, MAP kinase and NF-κB pathways[J]. Aging, 2017, 9(10): 2069-2082. doi: 10.18632/aging.101302
|
[18] |
VASHI R, PATEL B M. NRF2 in cardiovascular diseases: a Ray of hope[J]. J Cardiovasc Transl Res, 2021, 14(3): 573-586. doi: 10.1007/s12265-020-10083-8
|
[19] |
CUI B, ZHANG S L, WANG Y T, et al. Farrerol attenuates β-amyloid-induced oxidative stress and inflammation through Nrf2/Keap1 pathway in a microglia cell line[J]. Biomed Pharmacother, 2019, 109: 112-119. doi: 10.1016/j.biopha.2018.10.053
|
[20] |
徐小惠, 黄英华, 陈铭, 等. 葛根素通过SIRT1/PGC-1α信号通路对2型糖尿病小鼠胰腺线粒体的氧化应激损伤保护作用的研究[J]. 中国药理学通报, 2020, 36(10): 1373-1379. https://www.cnki.com.cn/Article/CJFDTOTAL-YAOL202010009.htm
|
[21] |
CAO F F, WANG Y, PENG B, et al. Effects of celastrol on Tau hyperphosphorylation and expression of HSF-1 and HSP70 in SH-SY5Y neuroblastoma cells induced by amyloid-β peptides[J]. Biotechnol Appl Biochem, 2018, 65(3): 390-396.
|
[22] |
SONG Y F, HOGSTRAND C, LING S C, et al. Creb-Pgc1α pathway modulates the interaction between lipid droplets and mitochondria and influences high fat diet-induced changes of lipid metabolism in the liver and isolated hepatocytes of yellow catfish[J]. J Nutr Biochem, 2020, 80: 108364.
|
[23] |
ZHAN X J, YAN C X, CHEN Y B, et al. Celastrol antagonizes high glucose-evoked podocyte injury, inflammation and insulin resistance by restoring the HO-1-mediated autophagy pathway[J]. Mol Immunol, 2018, 104: 61-68.
|
[24] |
CHEN S, LIU S, ZHAO L, et al. Heme oxygenase-1-mediated autophagy protects against oxidative damage in rat nucleus pulposus-derived mesenchymal stem cells[J]. Oxid Med Cell Longev, 2020, 2020: 9349762.
|
[25] |
王艳锋. 雷公藤多甙联合前列地尔治疗糖尿病肾病患者的疗效分析[J]. 实用临床医药杂志, 2021, 25(16): 65-69. https://www.cnki.com.cn/Article/CJFDTOTAL-XYZL202116015.htm
|